[ASAP] Discovery of OICR12694: A Novel, Potent, Selective, and Orally Biovailable BCL6 BTB Inhibitor

ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00502
Source: ACS Medicinal Chemistry Letters - Category: Chemistry Authors: Source Type: research
More News: Chemistry